Serum CTRP9 Reflects Coronary Collateralization in Nondiabetic Patients with Obstructive Coronary Artery Disease.
Ang GaoJinxing LiuYan LiuChengping HuYong ZhuYu Jie ZhouHongya HanYing-Xin ZhaoPublished in: BioMed research international (2022)
Serum CTRP9 reflects well-developed coronary collateralization in nondiabetic patients with obstructive CAD, and CTRP9 level ≥ 1.217 indicated a greater chance to forming well-developed coronary collaterals.